Name: Latest research reports of Cipla Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1475.3000 -0.50 (-0.03%)

NSE Jul 17, 2025 09:50 AM

Volume: 105.7K

Cipla Ltd.

30 Oct 2024

1475.30

-0.03%

Cipla (SELL): No meaningful incremental triggers until Goa plant clearance

Sell: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Earnings in line with our estimates on all fronts. However, US sales was down and 5% lower than our estimates in rupee terms

Number of FII/FPI investors increased from 1077 to 1114 in Mar 2025 qtr.